Center for Scientific Review; Notice of Closed Meetings, 31878-31879 [2019-14171]

Download as PDF jspears on DSK30JT082PROD with NOTICES 31878 Federal Register / Vol. 84, No. 128 / Wednesday, July 3, 2019 / Notices Court of Federal Claims No: 19–0737V 58. Sheila Amati, Monongahela, Pennsylvania, Court of Federal Claims No: 19–0738V 59. Michael Moses on behalf of P. M., Milwaukee, Wisconsin, Court of Federal Claims No: 19–0739V 60. Tina Coppersmith, Glen Falls, New York, Court of Federal Claims No: 19–0741V 61. Kelsey Metsker, Shawnee Mission, Kansas, Court of Federal Claims No: 19– 0743V 62. Patricia Taylor on behalf of A. S., San Antonio, Texas, Court of Federal Claims No: 19–0744V 63. Renee Smith, Luling, Louisiana, Court of Federal Claims No: 19–0745V 64. Virginia Van Zandt, San Francisco, California, Court of Federal Claims No: 19–0746V 65. John Heath and Marie Louise Heath on behalf of J. N. H., San Mateo, California, Court of Federal Claims No: 19–0749V 66. Linda Goggins, Pottstown, Pennsylvania, Court of Federal Claims No: 19–0751V 67. Sally Stokes, Washington, District of Columbia, Court of Federal Claims No: 19–0752V 68. Lance Basting, Eau Claire, Wisconsin, Court of Federal Claims No: 19–0753V 69. Wendy Jacobs, Mankato, Minnesota, Court of Federal Claims No: 19–0761V 70. Mark Santia, Erie, Pennsylvania, Court of Federal Claims No: 19–0762V 71. Young Kwan Jun, Brodheadsville, Pennsylvania, Court of Federal Claims No: 19–0764V 72. John F. Olson, Mankato, Minnesota, Court of Federal Claims No: 19–0768V 73. Yaniris Gonzalez, Brooklyn, New York, Court of Federal Claims No: 19–0769V 74. Chelsea Delvecchio, Tucson, Arizona, Court of Federal Claims No: 19–0772V 75. Beth Wyatt, Sedro-Woolley, Washington, Court of Federal Claims No: 19–0773V 76. Shawn Steiger, Boise, Idaho, Court of Federal Claims No: 19–0775V 77. Kathi Leopard, Greenwood, South Carolina, Court of Federal Claims No: 19–0776V 78. Ines Chicos on behalf of L.C., Sunnyside, New York, Court of Federal Claims No: 19–0778V 79. Linda Bergstrom, Park Ridge, Illinois, Court of Federal Claims No: 19–0784V 80. Natalie A. Woodson, Staten Island, New York, Court of Federal Claims No: 19– 0785V 81. Charley Boon, El Cajon, California, Court of Federal Claims No: 19–0788V 82. Arthur Cordisco, Boston, Massachusetts, Court of Federal Claims No: 19–0789V 83. Carol Culwell, Bryan, Texas, Court of Federal Claims No: 19–0790V 84. James G. Strouse, Greensboro, North Carolina, Court of Federal Claims No: 19–0793V 85. Stephanie Hetrick and Jonathan Hetrick on behalf of J H, Ruston, Louisiana, Court of Federal Claims No: 19–0795V 86. Cynthia Paul, Sarasota, Florida, Court of Federal Claims No: 19–0797V 87. Jeffrey Scott Cantrell, Greensboro, North Carolina, Court of Federal Claims No: 19–0799V 88. Kimble Lehman, Paducah, Kentucky, VerDate Sep<11>2014 19:23 Jul 02, 2019 Jkt 247001 Court of Federal Claims No: 19–0802V 89. Jeremy Williams, Washington, District of Columbia, Court of Federal Claims No: 19–0803V 90. Michael Thomas, Washington, District of Columbia, Court of Federal Claims No: 19–0804V 91. Keith Ratay, Washington, District of Columbia, Court of Federal Claims No: 19–0805V 92. Scott Weaver, Washington, District of Columbia, Court of Federal Claims No: 19–0806V [FR Doc. 2019–14124 Filed 7–2–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: International and Cooperative Projects 1. Date: July 26, 2019. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health; 6701 Rockledge Drive Bethesda, MD 20892, (Virtual Meeting). Contact Person: Brian H. Scott, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive Bethesda, MD 20892, 301– 827–7490, brianscott@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Planning for Non-Communicable Diseases and Disorders Research Training Programs. Date: July 26, 2019. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Brian H Scott, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review 6701 Rockledge Drive, Bethesda, MD 20892, 301– 827–7490, brianscott@mail.nih.gov. PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Molecular Virology, Cell Biology and Drug Development. Date: July 30–31, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: John C Pugh, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435– 2398, pughjohn@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: AIDS and Related Research. Date: July 30, 2019. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Barna Dey, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3184 Bethesda, MD 20892, 301–451–2796 bdey@ mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–18– 022/023: Tobacco Use and HIV in Low and Middle Income Countries. Date: July 30, 2019. Time: 11:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Mark P Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852 Bethesda, MD 20892, 301–435– 1775 rubertm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 18– 877: Early Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Agerelated Cognitive Deficits Date: July 30–31, 2019. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Unja Hayes, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive Bethesda, MD 20892, 301– 827–6830 unja.hayes@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurodegeneration. Date: July 30, 2019. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\03JYN1.SGM 03JYN1 Federal Register / Vol. 84, No. 128 / Wednesday, July 3, 2019 / Notices Place: National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Richard D Crosland, Ph.D., Scientific Review Officer, Center for Scientific Review National Institutes of Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 20892, 301–694– 7084 crosland@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 27, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–14171 Filed 7–2–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Meeting of the the Substance Abuse and Mental Health Services Administration’s National Advisory Council Substance Abuse and Mental Health Services Administration, HHS ACTION: Notice. AGENCY: Notice is hereby given of the meeting on July 23, 2019, of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) National Advisory Council (SAMHSA NAC). The meeting is open to the public and can be accessed via telephone only. Agenda with call-in information will be posted on the SAMHSA website prior to the meeting at: https:// www.samhsa.gov/about-us/advisorycouncils/meetings. The meeting will include remarks and dialogue from the Assistant Secretary for Mental Health and Substance Use; updates from the SAMHSA Centers Directors, and a council discussion with SAMHSA NAC members. DATES: July 23, 2019, 9:00 a.m. to 12:00 p.m. (EDT)/Open. ADDRESSES: The meeting will be held (virtually) at SAMHSA Headquarters, 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: Carlos Castillo, Committee Management Officer and, Designated Federal Official, SAMHSA National Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail); Telephone: (240) 276– 2787; Email: carlos.castillo@ samhsa.hhs.gov. jspears on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:23 Jul 02, 2019 Jkt 247001 The SAMHSA NAC was established to advise the Secretary, Department of Health and Human Services (HHS), and the Assistant Secretary for Mental Health and Substance Use, SAMHSA, to improve the provision of treatments and related services to individuals with respect to substance use and to improve prevention services, promote mental health, and protect legal rights of individuals with mental illness and individuals who are substance users. Interested persons may present data, information, or views orally or in writing, on issues pending before the Council. Written submissions must be forwarded to the contact person by July 16, 2019. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations must notify the contact person by July 16, 2019. Up to 3 minutes will be allotted for each presentation, and as time permits. To obtain the call-in number, access code, and/or web access link; submit written or brief oral comments; or request special accommodations for persons with disabilities, please register on-line at: https://nac.samhsa.gov/ Registration/meetingsRegistration.aspx, or communicate with SAMHSA’s Committee Management Officer, CAPT Carlos Castillo. Meeting information and a roster of Council members may be obtained either by accessing the SAMHSA Council’s website at https:// www.samhsa.gov/about-us/advisorycouncils/ or by contacting Carlos Castillo. Council Name: Substance Abuse and Mental Health Services Administration National Advisory Council. SUPPLEMENTARY INFORMATION: Dated: June 28, 2019. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2019–14241 Filed 7–2–19; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [USCBP–2019–0012] Notice of Decision on Domestic Interested Party Petition U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of decision on domestic interested party petition. AGENCY: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 31879 This document provides notice of U.S. Customs and Border Protection’s (CBP) decision regarding the tariff classification of certain steel special profiles for the manufacture of forklift truck masts and carriages. On April 3, 2019, CBP published in the Federal Register a Notice of Receipt of a Domestic Interested Party Petition, regarding the classification, under the Harmonized Tariff Schedule of the United States (HTSUS), of the subject steel special profiles. The Petition asked CBP to review the classification of these products and revoke New York Ruling Letter (NY) N293371, dated February 8, 2018. After reviewing 14 comments received in response to the Petition, CBP has issued a decision agreeing with Steel of West Virginia, Inc. (Petitioner) and revoking NY N293371, supra, as well as NY F83480, dated March 13, 2000, which pertained to merchandise substantially similar to the subject steel special profiles. This Notice advises Petitioner and all interested parties of CBP’s determination. DATES: July 3, 2019. FOR FURTHER INFORMATION CONTACT: Albena Peters, Chemicals, Petroleum, Metals and Miscellaneous Articles Branch, Regulations and Rulings, Office of Trade, U.S. Customs and Border Protection at (202) 325–0321. SUPPLEMENTARY INFORMATION: SUMMARY: Background This document concerns the tariff classification of certain steel special profiles for the manufacture of forklift truck masts and carriages. Classification of Nonalloy Steel Special Profiles Merchandise imported into the customs territory of the United States is classified under the HTSUS. The tariff classification of merchandise under the HTSUS is governed by the principles set forth in the General Rules of Interpretation (GRIs). The GRIs are part of the HTSUS and are to be considered statutory provisions of law for all purposes. See Section 1204 of the Omnibus Trade and Competitiveness Act of 1988, Public Law 100–418 (Aug. 23, 1988); 19 U.S.C. 3004. GRI 1 requires that classification be determined first according to the terms of the headings of the tariff schedule and any relative section or chapter notes and, provided such headings or notes do not otherwise require, then according to the other GRIs. See GRI 1, HTSUS (2019). GRI 6 prescribes that, for legal purposes, the classification of goods in the subheadings of a heading shall be determined according to the terms of E:\FR\FM\03JYN1.SGM 03JYN1

Agencies

[Federal Register Volume 84, Number 128 (Wednesday, July 3, 2019)]
[Notices]
[Pages 31878-31879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14171]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: International and Cooperative Projects 1.
    Date: July 26, 2019.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health; 6701 Rockledge Drive 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Brian H. Scott, Ph.D., Scientific Review 
Officer, National Institutes of Health, Center for Scientific 
Review, 6701 Rockledge Drive Bethesda, MD 20892, 301-827-7490, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Planning for Non-Communicable Diseases and 
Disorders Research Training Programs.
    Date: July 26, 2019.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Brian H Scott, Ph.D., Scientific Review Officer, 
National Institutes of Health, Center for Scientific Review 6701 
Rockledge Drive, Bethesda, MD 20892, 301-827-7490, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Molecular Virology, Cell Biology and Drug 
Development.
    Date: July 30-31, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: John C Pugh, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435-
2398, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: AIDS and Related Research.
    Date: July 30, 2019.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Barna Dey, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3184 Bethesda, MD 20892, 301-451-2796 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-18-022/023: Tobacco Use and HIV in Low and Middle Income 
Countries.
    Date: July 30, 2019.
    Time: 11:30 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mark P Rubert, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5218, MSC 7852 Bethesda, MD 20892, 301-435-
1775 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR 18-877: Early Stage Clinical Trials for the Spectrum of 
Alzheimer's Disease and Age-related Cognitive Deficits
    Date: July 30-31, 2019.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Unja Hayes, Ph.D., Scientific Review Officer, 
National Institutes of Health, Center for Scientific Review, 6701 
Rockledge Drive Bethesda, MD 20892, 301-827-6830 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neurodegeneration.
    Date: July 30, 2019.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 31879]]

    Place: National Institutes of Health, 6701 Rockledge Drive 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Richard D Crosland, Ph.D., Scientific Review 
Officer, Center for Scientific Review National Institutes of Health, 
6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 20892, 301-
694-7084 [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 27, 2019.
Melanie J. Pantoja,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-14171 Filed 7-2-19; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.